| Roche Pharma (Schweiz) AG - Erivedge, Kapseln | | 62497 | | 01 | | Erivedge | | Kapseln | | L01XJ01 | | Vismodegib | | 30.05.2013 | | |
| | Composition | | vismodegibum 150 mg, cellulosum microcristallinum, lactosum monohydricum 71.5 mg, natrii laurilsulfas, povidonum K 29-32, carboxymethylamylum natricum, talcum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (nigrum), Drucktinte: lacca, E 172 (nigrum), excipiens pro capsula corresp. natrium 1.09 - 1.34 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Vismodegibum | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Vismodegibum | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Lactose Monohydrate | 71.5 mg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Povidonum K | 29-32 | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 Gélule(s) | 4882.26 | 5317.00 | A | LS | Oui |
|
|
